BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26391193)

  • 1. Tumour-promoting role of SOCS1 in colorectal cancer cells.
    Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
    Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SOCS1 knockdown sensitize anti-tumor activity of IFN-alpha2a-NGR].
    Huang QC; Lei XY; Liu Y; Sui WJ; Li S; Zhang YQ; Yan Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):412-5. PubMed ID: 20423643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
    Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
    Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
    J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice.
    Hanada T; Kobayashi T; Chinen T; Saeki K; Takaki H; Koga K; Minoda Y; Sanada T; Yoshioka T; Mimata H; Kato S; Yoshimura A
    J Exp Med; 2006 Jun; 203(6):1391-7. PubMed ID: 16717119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.
    David M; Naudin C; Letourneur M; Polrot M; Renoir JM; Lazar V; Dessen P; Roche S; Bertoglio J; Pierre J
    Mol Oncol; 2014 Jul; 8(5):942-55. PubMed ID: 24726456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
    Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
    Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
    Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
    Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
    Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
    Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
    Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
    Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.
    Chen J; Wei Y; Feng Q; Ren L; He G; Chang W; Zhu D; Yi T; Lin Q; Tang W; Xu J; Qin X
    Int J Oncol; 2016 Apr; 48(4):1628-38. PubMed ID: 26847263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
    Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
    Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
    Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
    Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska O; Bryś M; Krajewska WM; Łukomski M
    Folia Histochem Cytobiol; 2009 Jan; 47(3):401-10. PubMed ID: 20164024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
    PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.
    Han Y; Tan Y; Zhao Y; Zhang Y; He X; Yu L; Jiang H; Lu H; Tian H
    J Cell Mol Med; 2020 May; 24(10):5491-5500. PubMed ID: 32227572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.